U.S. President Donald Trump on Sunday said that the Food and Drug Administration (FDA) has announced an emergency use authorization for the use of convalescent plasma in helping treat patients with COVID-19. He also claimed the treatment could reduce the mortality by 35 per cent.
Health
Coronavirus: Trump says FDA has authorized emergency use of convalescent plasma for COVID-19
More Videos
-
Majority of amputations done on Canadian diabetics could have been prevented, study finds
-
Health Matters: First Nations community has been under boil-water advisory for 29 years
-
Iron 101: Pharmacist on health benefits, sources of mineral for body
-
Surrogates face higher complication risk, ICES study says
-
Health Matters: Ottawa launches new pandemic preparedness agency
-
‘Suicide pod’ death in Switzerland sparks controversy
You are viewing an Accelerated Mobile Webpage.
View Original Article